ArticleEpidemiology and infection2013
Campylobacter seroconversion rates in selected countries in the European Union.
Article in Epidemiology and infection, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 42 citations in OpenAlex.
- Article
- The European Union One Health 2024 Zoonoses Report.EFSA journal. European Food Safety Authority · 2025Article
- Impact of the COVID-19 pandemic on five food- and waterborne diseases in six European countries, 2016-21.European journal of public health · 2025Article
- The European Union One Health 2023 Zoonoses report.EFSA journal. European Food Safety Authority · 2024Article
- Salivary Antibody Responses to Potentially Waterborne and Environmentally Transmitted Infections Among Two Tribal Nations in the Southwest United States.Journal of epidemiology and global health · 2024Article
- Campylobacter presence on Dutch broiler farms and associated risk factors.Poultry science · 2024Article
- Estimating seroconversion rates accounting for repeated infections by approximate Bayesian computation.Statistics in medicine · 2023Article
- The European Union One Health 2022 Zoonoses Report.EFSA journal. European Food Safety Authority · 2023Article
- Repetitive non-typhoidal Salmonella exposure is an environmental risk factor for colon cancer and tumor growth.Cell reports. Medicine · 2022Article
- The European Union One Health 2021 Zoonoses Report.EFSA journal. European Food Safety Authority · 2022Article
- Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts' meeting on serum biomarkers.PLoS neglected tropical diseases · 2022Article
- The European Union One Health 2020 Zoonoses Report.EFSA journal. European Food Safety Authority · 2021Article
- The European Union One Health 2019 Zoonoses Report.EFSA journal. European Food Safety Authority · 2021Article
- Linking longitudinal and cross-sectional biomarker data to understand host-pathogen dynamics: Leptospira in California sea lions (Zalophus californianus) as a case study.PLoS neglected tropical diseases · 2020Article
- The European Union One Health 2018 Zoonoses Report.EFSA journal. European Food Safety Authority · 2019Article
- Enteropathogen antibody dynamics and force of infection among children in low-resource settings.eLife · 2019Article
- Identifying the source of food-borne disease outbreaks: An application of Bayesian variable selection.Statistical methods in medical research · 2019Article
- Climate, human behaviour or environment: individual-based modelling of Campylobacter seasonality and strategies to reduce disease burden.Journal of translational medicine · 2019Article
- Article
- Integrated Serologic Surveillance of Population Immunity and Disease Transmission.Emerging infectious diseases · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 7 institutions in 7 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a major foodborne pathogen, Campylobacter is frequently isolated from food sources of animal origin. In contrast, human Campylobacter illness is relatively rare, but has a considerable health burden due to acute enteric illness as well as severe sequelae. To study silent transmission, serum antibodies can be used as biomarkers to estimate seroconversion rates, as a proxy for infection pressure. This novel approach to serology shows that infections are much more common than disease, possibly because most infections remain asymptomatic. This study used antibody titres measured in serum samples collected from healthy subjects selected randomly in the general population from several countries in the European Union (EU). Estimates of seroconversion rates to Campylobacter were calculated for seven countries: Romania, Poland, Italy, France, Finland, Denmark and The Netherlands. Results indicate high infection pressures in all these countries, slightly increasing in Eastern EU countries. Of these countries, the differences in rates of notified illnesses are much greater, with low numbers in France and Poland, possibly indicating lower probability of detection due to differences in the notification systems, but in the latter case it cannot be excluded that more frequent exposure confers better protection due to acquired immunity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.